Novabridge Biosciences (NBP) Return on Investment ROI from the fourth quarter of 2025 to fourth quarter of 2024 and for the year 2025, average high and low, overall ranking from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Novabridge Biosciences  (NBP)


Novabridge Biosciences's ROI from its fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Novabridge Biosciences's ROI in the fourth quarter of 2025?
Novabridge Biosciences recorded a cumulative net loss of $-88 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on investment (ROI) of -38.42%.

Within the Healthcare sector 753 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2025 from to 4536.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Investment Change TTM 6.77 % -12.87 % -23.49 % -24.61 % -33.31 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 232 259 197 231 202
Return On Investment (TTM) -38.42 % -10 % -10.46 % -9.97 % -10.32 %
NBP's Overall Ranking # 4536 # # # #
Seq. Investment Change TTM 3.38 % 4.63 % -4.65 % 3.52 % -15.63 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -88 -22 -22 -22 -22

NBP Company Profile >> Back to NBP Roi Comparisons >> See Annual NBP Return On Investment



Return On Investment NBP's Ranking
Within: No.
Industry # 345
Sector # 754
Overall # 4536

Return On Investment Statistics
High Average Low
8.36 %
-61.14 %
-129.23 %
(Dec 31 2020)   (Dec 31 2019)







Financial Statements
Novabridge Biosciences's IV. Quarter Investments $ 232 Millions NBP's Balance sheet
Novabridge Biosciences's IV. Quarter Income $ -88 Millions Quarterly NBP's Income Statement
NBP's Income by Division See NBP's Income by Division


NBP Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 232 202 362 479 783
Y / Y Investment Growth 14.91 % -44.13 % -24.54 % -38.84 % -10.06 %
Net Income in Millions -46 -22 -208 -371 -366
Y / Y Net Income Growth - - - - -
Annual Return On Investment -19.93 % -11 % -57.45 % -77.43 % -46.7 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
NBP's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for NBP's Competitors
Subscribers only: Roi for Novabridge Biosciences's Suppliers
Subscribers only: Return On Investment for NBP's Customers

Other Ratios
NBP's Roa NBP's Inventory Turnover Ratio NBP's Growth Rates NBP's Dividend Statistics
NBP's Profitability Ratios NBP's Asset Turnover Ratio NBP's Dividend Growth
NBP's Roe NBP's Valuation Ratios NBP's Financial Strength Ratios NBP's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2025, within Healthcare Sector ROI

Date modified: 2026-07-07T12:24:41+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.